M
M Curtis
Publications - 5
Citations - 268
M Curtis is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 245 citations.
Papers
More filters
Journal ArticleDOI
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.
D J Stewart,J D Hilton,J M O Arnold,J Gregoire,A Rivard,Stephen L. Archer,F Charbonneau,Eric A. Cohen,M Curtis,C.E. Buller,F O Mendelsohn,Nabil Dib,P Page,J Ducas,S Plante,J Sullivan,Jennifer Macko,Camilla Sandvad Rasmussen,Paul D. Kessler,Henrik S. Rasmussen +19 more
TL;DR: Administration of AdVEGF121 by direct intramyocardial injections resulted in objective improvement in exercise-induced ischemia in patients with refractory ischemic heart disease.
Journal ArticleDOI
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Kush Patel,Alexandra J. Lansky,Dean J. Kereiakes,Stephan Windecker,Ecaterina Cristea,Cody Pietras,Ovidiu Dressler,M. Issever,M Curtis,Barry D. Bertolet,James P. Zidar,Pieter C. Smits,Victor Alfonso Jimenez Diaz,Brent T. McLaurin,David A Brogno,Luc Janssens,Mathias Vrolix,Iván Gómez-Blázquez,Zakir Sahul,Ameer Kabour,Luisa Salido,Michael W. Cleman,Shigeru Saito,Martin B. Leon,Andreas Baumbach +24 more
TL;DR: The PIONEER III clinical trial as mentioned in this paper showed that the Supreme DES is as effective and safe at 1 year compared with the standard durable-polymer, everolimus-eluting stents across a broad spectrum of lesion complexity.
Journal ArticleDOI
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy
Yasin Hussain,Shigeru Saito,M Curtis,Dean J. Kereiakes,Andreas Baumbach,James P. Zidar,Brent T. McLaurin,Nabil Dib,Pieter C. Smits,Victor Alfonso Jimenez Diaz,Angel Cequier,Sjoerd H. Hofma,Cody Pietras,Ovidiu Dressler,M. Issever,Stephan Windecker,Martin B. Leon,Alexandra J. Lansky +17 more
Journal ArticleDOI
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus
Alexander Thomas,Dean J. Kereiakes,Andreas Baumbach,Stephan Windecker,Cody Pietras,Ovidiu Dressler,M. Issever,M Curtis,Barry D. Bertolet,James P. Zidar,Pieter C. Smits,Victor Alfonso Jimenez Diaz,Brent T. McLaurin,Angel Cequier,Akihiko Takahashi,Louis Cannon,Giovanni Amoroso,Tsunekazu Kakuta,Shigeru Saito,Martin B. Leon,Alexandra J. Lansky +20 more
TL;DR: In this paper , a biodegradable polymer sirolimus-eluting stent called Supreme DES was proposed to synchronize early drug delivery, limiting the potential for long-term inflammatory response.
Journal ArticleDOI
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III
Philippe Garot,Martin B. Leon,S. Saito,Andreas Baumbach,Dean J. Kereiakes,Stephan Windecker,Cody Pietras,Ovidiu Dressler,M. Issever,M Curtis,Barry D. Bertolet,James P. Zidar,Pieter C. Smits,Victor Alfonso Jimenez Diaz,Brent T. McLaurin,Angel Cequier,Sjoerd H. Hofma,Nabil Dib,Atsuo Namiki,Akihiko Takahashi,Tsunekazu Kakuta,Atsushi Hirohata,Alexandra J. Lansky +22 more
TL;DR: The PIONEER III trial showed the 12-month safety and efficacy of the Supreme drug-eluting stent (DES) vs the durable polymer everolimus-eluted stent as mentioned in this paper .